Therapeutic Asset Ratings
13,155 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Bortezomib
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Zhejiang Cancer Hospital
P2
B
(61)
Brentuximab Vedotin
Extranodal Nasal NK/T Cell Lymphoma
Shanghai Zhongshan Hospital
P2
B
(61)
Brentuximab Vedotin
Angioimmunoblastic T-Cell Lymphoma
Northwestern University
P2
B
(61)
Brentuximab Vedotin
Sezary Syndrome
City of Hope Medical Center
P2
B
(61)
BUSULFANUM
Alpha-Mannosidosis
Masonic Cancer Center, University of Minnesota
P2
B
(61)
BUSULFANUM
Beta Thalassemia
New York Medical College
P2
B
(61)
BUSULFANUM
Hematopoietic And Lymphoid System Neoplasm
National Cancer Institute (NCI)
P2
B
(61)
BUSULFANUM
Mucopolysaccharidosis Type 6
Masonic Cancer Center, University of Minnesota
P2
B
(61)
BUSULFANUM
Myelodysplastic Syndrome With Excess Blasts-1
Fred Hutchinson Cancer Center
P2
B
(61)
BUSULFANUM
Myelofibrosis
City of Hope Medical Center
P2
B
(61)
BUSULFANUM
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Xianmin Song, MD
P2
B
(61)
BUSULFANUM
Aplastic Anemia
Masonic Cancer Center, University of Minnesota
P2
B
(61)
Capecitabine
Biliary Tract Cancer
Zhejiang Cancer Hospital
P2
B
(61)
Capecitabine
Brain Cancer
Northwell Health
P2
B
(61)
Capecitabine
Esophageal Cancer
Shenyang Sunshine Pharmaceutical Co., LTD.
P2
B
(61)
Carboplatin
BRCA2-Related Cancer Predisposition
Okayama University
P2
B
(61)
Carboplatin
Esophageal Cancer
Neonc Technologies, Inc.
P2
B
(61)
Carboplatin
Prostate Neuroendocrine Neoplasm
Phanes Therapeutics
P2
B
(61)
Carboplatin
Gastric Neoplasm
Merck Sharp & Dohme LLC
P2
B
(61)
Carboplatin
Uterine Cervix Neoplasm
Eli Lilly and Company
P2
B
(61)
Carotuximab
Castration-Resistant Prostate Carcinoma
Edwin Posadas, MD
P2
B
(61)
Cediranib
Neoplasm
AstraZeneca
P2
B
(61)
Cediranib
Endometrial Mixed Adenocarcinoma
National Cancer Institute (NCI)
P2
B
(61)
Cediranib
Endometrial Serous Adenocarcinoma
National Cancer Institute (NCI)
P2
B
(61)
Cetuximab
Breast Cancer
Pfizer
P2
B
(61)
Showing 1351 to 1375 of 13,155 assets
Previous
Page 55 of 527
Next